Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer

INTRODUCTION: Inhibition of proprotein convertase subtilisin/kexin 9 (PCSK9) is an effective therapeutic tool for lowering low-density lipoprotein cholesterol (LDL-C). There is no available evidence on the efficacy and safety of PCSK9 inhibitors in non-cardiovascular diseases, particularly cancer. T...

Full description

Saved in:
Bibliographic Details
Published in:Arch Med Sci
Main Authors: Momtazi-Borojeni, Amir Abbas, Nik, Maryam Ebrahimi, Jaafari, Mahmoud Reza, Banach, Maciej, Sahebkar, Amirhossein
Format: Artigo
Language:Inglês
Published: Termedia Publishing House 2019
Subjects:
Hot Topics
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524180/
https://ncbi.nlm.nih.gov/pubmed/31110520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2019.84732
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items